Fundraising Fox
Risklick
1 known investors
Find your way into Risklick
Sign up to find every way you can get introduced to Risklick
- Your email: who you already know at Risklick, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Risklick team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.
Founders & leadership
S
Sven
B
Beat
I
IngridPhysician
Board
ME
Matthias EggerProfessor of Epidemiology
Investors · 1
Frequently asked questions
- What does Risklick do?
- RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.
- Who are Risklick's investors?
- Risklick's investors include Debiopharm Innovation Fund.